-
Mashup Score: 9Advancements in Aggressive Non-Hodgkin Lymphomas (NHL) | Leukemia and Lymphoma Society - 10 day(s) ago
Join us for a free webinar covering the latest information for patients and caregivers. To register by phone, call (877) 264-4949. Topics Covered We invite you to learn more about: How your NHL subtype determines treatment goals and strategies Current and emerging therapies for aggressive subtypes of NHL Methods to manage side effects The importance of discussing quality-of-life issues with your healthcare team Speaker Joshua Brody, MD Director, Lymphoma Immunotherapy Program Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine New York, NY Submit a question for Dr. Brody to answer during the Q&A session. Program Support Support for this program provided by Genentech, a member of the Roche Group. < Back to Webcasts
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 15Targeting Microenvironment Determinants in Peripheral T-cell Lymphoma | Leukemia and Lymphoma Society - 11 day(s) ago
Peripheral T-cell lymphomas are highly aggressive blood cancer that have very poor survival rate, highlighting the need for new therapies to improve patient survival. We aim to improve our understanding of the characteristics of the individual cancer cells and their interaction with surrounding cells in the tumor environment with the goal of identifying new drugs that we can validate in preclinical models and move into more efficient treatments for lymphoma patients.
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
From the lab to potential lifesaving therapies—Dr. @teresa_palomero is on a mission to transform how we understand and treat Peripheral T-cell lymphomas (PTCL). 🔬🧬 Her work could be a game-changer for patients facing this aggressive cancer. Learn more 👉 https://t.co/DRduckCZOI… https://t.co/lYvDywZ0d4 https://t.co/Xn5llpR3Gf
-
-
Mashup Score: 1Myelodysplastic Syndromes | Symptoms, Treatments, FAQs | LLS - 28 day(s) ago
Myelodysplastic Syndromes are a group of diseases that affect the blood and marrow. Learn more about the development of MDS, possible risk factors.
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
To learn more about this blood cancer 👉 https://t.co/DfC5tPZstU https://t.co/g4oP40jMdg
-
-
Mashup Score: 2
Protecting Patients from Junk Insurance > Page Components
Source: www.lls.orgCategories: General Medicine News, Onc News and JournalsTweet-
Junk insurance policies: they’re just tricks, with no treats. That’s why Americans on ALL sides of the aisle agree that they should be required to follow the same rules as traditional insurance. Learn more: https://t.co/MJb90xNRox #NoJunkPlans https://t.co/ebBSLddXDz
-
-
Mashup Score: 0
LLS Scholarship for Blood Cancer Survivors > Page Components
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
Help us support even more survivors through The LLS Scholarship for Blood Cancer Survivors, offering up to $7,500 for blood cancer survivors pursuing vocational, trade, two-year, or four-year undergraduate education. Learn more or apply today here 👉 https://t.co/aWjI1262ZH… https://t.co/2KAgrh6khC
-
-
Mashup Score: 10Targeting the microenvironment to increase immunity and immunotherapy response in DLBCL | Leukemia and Lymphoma Society - 1 month(s) ago
To survive and proliferate lymphoma cells must co-opt normal cells residing the tumor microenvironment. This process results in the suppression of the activity of immune cells that otherwise will attack cancer cells. In this project we will develop a novel oral treatment that by acting on the microenvironment will restore lymphoma immunity and increase the activity of immunotherapy.
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
Meet @LCerchietti, MD! 🔬🧬 We’re proud to support Dr. Cerchietti’s research to help the immune system fight aggressive blood cancers like diffuse large B-cell lymphoma (DLBCL) with innovative treatments. Learn more 👉 https://t.co/2kxS9GUHxx #lymsm https://t.co/xgQnWozrjI
-
-
Mashup Score: 2
Protecting Patients from Junk Insurance > Page Components
Source: www.lls.orgCategories: General Medicine News, Onc News and JournalsTweet-
Junk insurance policies: they’re just tricks, with no treats. That’s why Americans on ALL sides of the aisle agree that they should be required to follow the same rules as traditional insurance. Learn more: https://t.co/MJb90xNRox #NoJunkPlans https://t.co/ebBSLddXDz
-
-
Mashup Score: 0Information Specialists | Leukemia and Lymphoma Society - 2 month(s) ago
Information Specialists > Page Components
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
Connect with real experts, not automated systems. Our oncology social workers and nurses are here to answer your blood cancer questions with care. Reach out to us today 👉 https://t.co/zpJAjJNnzO
-
-
Mashup Score: 0Information Specialists | Leukemia and Lymphoma Society - 2 month(s) ago
Information Specialists > Page Components
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
You’re not alone. Speak with oncology social workers and nurses for free blood cancer support and information 👉 https://t.co/lWHtmB0jkH
-
-
Mashup Score: 0Patient Support | Leukemia and Lymphoma Society - 2 month(s) ago
Patient Support > Page Components
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
We have free resources and information on all blood cancers. Get in touch now 👉 https://t.co/W2mK9smdrC (3/3) https://t.co/W96lhU48Vj
-
How is the landscape of #lymphoma treatment evolving? Get an inside look at new developments in aggressive non-Hodgkin lymphomas in our upcoming webcast with @JoshuaBrodyMD from @IcahnMountSinai. Secure your spot 👉 https://t.co/XdGC3wLPqY #lymsm https://t.co/VQHwjGBbWS